A team of researchers from Manchester University, in the UK, developed a new method to produce antibiotics using gene editing techniques, according to a study published in Nature Communications. This
All posts in CRISPR
On the occasion of the publication of a new edition of the collective work Plant Biotechnology. Experience and Future Prospects, edited by Agnès Ricroch, Surinder Chopra, Marcel Kuntz (Springer, 2021)
End of April 2021, the European Commission published a report on “new genomic techniques” which was awaited by developers of these biotechnologies, since it was expected to have major implications
EU report supports changes in legislation with the potential to allow gene editing in agriculture (1). However, the debate is ongoing, and organic farmers want to continue to label products
New Genomic Techniques (NGTs): the European Commission Opens the Door. An Historical Challenge for French EU Presidency.
- Features -
On April 29, 2021, the European Commission (EC) opened the debate on the regulatory status of New Genomic Techniques (NGTs) in the European Union (EU) by publishing a position paper[1].
Genome editing biotechnologies: UEAA calls for a revision of European regulations on genetically modified organisms.
- Features -
The Nobel Prize in Chemistry was awarded in this year 2020 to Emmanuelle Charpentier and Jennifer Doudna for the discovery of a new genome editing tool, so-called CRISPR-Cas technique, a
We echoed the need to revise the European regulations on GMOs after the judgment of July 25, 2018 of the Court of Justice of the European Union ruling that all
The acceptance of genetically engineered food is a divisive topic that is deeply embedded in the ongoing debate around climate change, sustainability and food security. Despite studies finding that genetically
The groundbreaking documentary Food Evolution offered the general public a science-based introduction to crop biotechnology, revealing how activists attack it and debunking some of the more pernicious myths about GMOs
In the September 2019 issue of Nature Biotechnology, a collective of scientists mostly from Insilico Medicine, led by Alex Zhavoronkov, CEO and founder of the company, published a landmark article.